Serum total testosterone level and identification of late-onset hypogonadism: a community-based study - PubMed (original) (raw)

Serum total testosterone level and identification of late-onset hypogonadism: a community-based study

Sungmin Kang et al. Korean J Urol. 2013 Sep.

Abstract

Purpose: Late-onset hypogonadism (LOH) in aging males is a clinical and biochemical syndrome characterized by a decline in serum testosterone levels. LOH results in various physical and mental disabilities. We evaluated the relationship between serum testosterone levels and symptoms of LOH.

Materials and methods: During an andropause screening program, we examined responses to the Saint Louis university androgen deficiency in aging males (ADAM) questionnaire and results on the International Index of Erectile Function (IIEF-5) in terms of clinical symptoms and evaluated serum total testosterone levels for a biochemical diagnosis of LOH in healthy community-living volunteers aged over 40 years.

Results: The mean age of the 534 men was 59.1 years (range, 40 to 79 years), and their mean serum testosterone level was 464.1±171.9 ng/dL. The serum testosterone level decreased significantly with age. There was a 92.5% positive response rate to the ADAM questionnaire. The percentage of patients whose serum testosterone level was <350 ng/dL among those with a positive response to the ADAM questionnaire was 25.6% (137 patients). The mean serum testosterone level among patients with a positive or negative ADAM questionnaire was 472.4±198.5 ng/dL and 487.3±165.7 ng/dL, respectively (p>0.05). There was no significant correlation between IIEF-5 scores and serum testosterone levels.

Conclusions: Among men over 40 years of age, 25.6% met the clinical and biochemical diagnostic criteria for LOH. There was no relationship between serum testosterone levels and symptoms of LOH.

Keywords: Aging; Andropause; Testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

FIG. 1

FIG. 1

Serum total testosterone level according to age. r2=0.009, p=0.04.

FIG. 2

FIG. 2

International index of erectile function (IIEF-5) score according to total testosterone level. r2=0.004, p=0.112.

References

    1. Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. J Clin Endocrinol Metab. 1995;80:2394–2403. - PubMed
    1. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73:1016–1025. - PubMed
    1. Werner AA. The male climacteric: report of two hundred and seventy-three cases. J Am Med Assoc. 1946;132:188–194. - PubMed
    1. Kim SW, Oh SJ, Paick JS, Kim SC. Development of the Korean-translation of androgen deficiency in aging males (ADAM) questionnaire. Korean J Urol. 2004;45:674–679.
    1. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49:1239–1242. - PubMed

LinkOut - more resources